• About
  • Pressroom
  • Resources
  • Get Updates
Health GAP (Global Access Project)
  • Issues
    • Access to Medicines
    • Funding the Fight
    • Health Justice
    • Transparency & Accountability
      • PEPFAR Watch
  • Blog
  • Our Impact
  • Take Action
    • Do something now
DONATE
May 9, 2019 | Brittany Herrick

Gilead says only Teva can market Truvada generic

NGOs claim victory over U.S. funding cut to South Africa’s HIV programs
Generic PrEP to Arrive in September 2020, but Will Big Savings Follow?
Related Posts
Access to Medicines

Pharma’s alleged “brea...

PEPFAR Watch

PEPFAR is Rolling the Cloc...

Access to Medicines

Pharma Pricing Secrecy Run...

About Us

  • Our Story
  • Our Impact
  • Team
  • Financials
  • Work With Us

Pressroom

  • Media Inquiries
  • Health GAP in the News
  • Press Releases

Resources

  • Most Recent
  • Explore

Follow Us